The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
Open accessAbstract
Accumulating evidence supports an association between depression and inflammatory processes, a connection that seems to be bidirectional. Clinical trials have indicated antidepressant treatment effects for anti-inflammatory agents, both as add-on treatment and as monotherapy. In particular, nonsteroidal anti-inflammatory drugs (NSAIDs) and cytokine-inhibitors have shown antidepressant treatment effects compared to placebo, but also statins, poly-unsaturated fatty acids, pioglitazone, minocycline, modafinil, and corticosteroids may yield antidepressant treatment effects. However, the complexity of the inflammatory cascade, limited clinical evidence, and the risk for side effects stress cautiousness before clinical application. Thus, despite proof-of-concept studies of anti-inflammatory treatment effects in depression, important challenges remain to be investigated. Within this paper, we review the association between inflammation and depression together with the current evidence on use of anti-inflammatory treatment in depression. Based on this, we address the questions and challenges that seem most important and relevant to future studies, such as timing, most effective treatment lengths and identification of subgroups of patients potentially responding better to different anti-inflammatory treatment regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On one hand, drugs that target IRFs have been proposed for treating psychiatric disorders, including major depression (MDD)10–12, schizophrenia (SCZ)13 and bipolar disorder (BD)14, particularly in a subset of patients with chronic inflammation10”
From Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses (2019) · cites this paper as [11]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“CVDs in old age often develop in the context of multimorbidity and frailty”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [143]
Experimental — accuracy not yet measuredIn the citing paper
“inflammation also contributes to the pathogenesis of other chronic non-CVDs — such as anaemia, cancer, type 2 diabetes, dementia, osteoporosis, sarcopenia, chronic kidney disease, and depression”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [143]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 1×
“Furthermore, stimulation of peripheral nerves, in particular the vagus nerve, may represent another pathway between the CNS and the peripheral immune system [17].”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 11×
“Their effect on the immune system mainly occurs via secretion of pro-inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α) or interleukin-6 (IL-6), and anti-inflammatory cytokines, such as IL-10 [12].”
BackgroundInfluentialStructural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · cited 11×
“In addition, it has been suggested that the endothelial cells of the blood-brain barrier may play a role in transmitting the signals from peripheral cytokines into the CNS, either directly by an active transport of cytokines [18], or indirectly via second messengers [19].”
BackgroundInfluentialAssociations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766 · cited 4×
“In particular, acutely developed depressive episodes may be associated with a more pronounced inflammatory response [2, 33].”
BackgroundInfluentialCardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519 · cited 1×
“However, an increased risk for severe cardiovascular events was soon recognized [44, 45], which resulted in the withdrawal of rofecoxib in 2004.”
BackgroundCardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A., Wittes, J., Fowler, R., Finn, P., Anderson, W. F., Zauber, A., Hawk, E., & Bertagnolli, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050405 · Cited by 2,052
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · cited 4×
“Also monotherapy with cytokine-inhibitors has shown better antidepressant treatment effects compared to placebo after 12 [4, 49, 51] and 24 weeks [50] without increased risks for infections [7].”
BackgroundInfluential
Research works printed but not linked: 1
- [80]Solomon D.H. Avorn J. Stürmer T. Glynn R.J. Mogun H. Schneeweiss S. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum. 2006 54 5 1378 1389 [http://dx.doi.org/10.1002/art.21887]. [PMID: 16645966]. 16645966 · DOI · Paper page
Cited by
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Post-stroke depression: Mechanisms and pharmacological treatment
Villa, R. F., Ferrari, F., & Moretti, A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.005 · Cited by 532
Köhler‐Forsberg, O., N. Lydholm, C., Hjorthøj, C., Nordentoft, M., Mors, O., & Benros, M. E. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13016 · Cited by 432
Self-citationYuan, N., Chen, Y., Xia, Y., Dai, J., & Liu, C. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0570-y · Cited by 428
Beyond a neurotransmitter: The role of serotonin in inflammation and immunity
Wu, H., Denna, T. H., Storkersen, J. N., & Gerriets, V. A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.015 · Cited by 338
Metadata
- Authors
- Kohler, O., Krogh, J., Mors, O., & Eriksen Benros, M.
- Venue
- Current Neuropharmacology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2016-08-26
- Volume
- 14
- Issue
- 7
- Pages
- 732-742
- ISSN
- 1570-159X (ISSN-L)
- PMC
- PMC5050394
- OpenAlex
- W2194924010
- Cited by
- 516
- References
- 81
- Citations by year
- 2026: 24 · 2025: 52 · 2024: 71 · 2023: 70 · 2022: 74 · 2021: 78 · 2020: 55 · 2019: 45 · 2018: 24 · 2017: 18 · 2016: 4
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc
- Locations
- Current Neuropharmacology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Lundbeckfonden (R155-2014-1724)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- depression, inflammation, anti-inflammatory therapy, antidepressant effects, nonsteroidal anti-inflammatory drugs, cytokine inhibitors, statins, polyunsaturated fatty acids, pioglitazone, minocycline, modafinil, corticosteroids, treatment response subgroups
- MeSH terms
- Anti-Inflammatory Agents, Antidepressive Agents, Brain, Depressive Disorder, Humans, Inflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammation in Depression and the Potential for Anti-Inflammatory Treatment. https://app.cochat.ai/papers/10.2174/1570159x14666151208113700
- The paper
- Kohler, O., Krogh, J., Mors, O., & Eriksen Benros, M. (2016). Inflammation in Depression and the Potential for Anti-Inflammatory Treatment. Current Neuropharmacology. https://doi.org/10.2174/1570159x14666151208113700
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.